Ensysce Biosciences Inc reports results for the quarter ended September 30 - Earnings Summary

Ensysce Biosciences

15/11/2024 22:00

* Ensysce Biosciences Inc  ENSC.OQ  reported quarterly
adjusted
earnings of 7 cents​​ per share for the quarter ended September
30, higher than the same quarter last year, when the company
reported EPS of -87 cents.  The mean expectation of two analysts
for the quarter was for a loss of 29 cents per share. Wall
Street expected results to range from -42 cents to -17 cents per
share.
    * Revenue rose 685.3% to $3.42 million from a year ago;
analysts
expected $250.00 thousand. 
    * Ensysce Biosciences Inc's reported EPS for the quarter was
7
cents​.
    * The company reported quarterly net income of $662
thousand.
    * Ensysce Biosciences Inc shares had risen by 164.9% this
quarter and lost 40.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 7.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * 
    * Wall Street's median 12-month price target for Ensysce
Biosciences Inc is $8.30 

This summary was machine generated from LSEG data November 15 at
10:00 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.29          0.07           Beat
 Jun. 30 2024      -0.39          -0.22          Beat
 Mar. 31 2024      -0.90          -0.55          Beat
 Dec. 31 2023      -0.87          -1.37          Missed